Potentially Inappropriate Prescriptions in Ambulatory Elderly Patients Living in Rural Areas of Romania Using STOPP/START (Version 2) Criteria

References

• Eurostat. Population structure and ageing; 2019 Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Population_structure_and_ageing&oldid=298662. Accessed 219, 2020.
   Google Scholar
• European Commission. The 2018 ageing report: economic and budgetary projections for the EU member states (2016–2070); 2018 Available from: https://ec.europa.eu/info/sites/info/files/economy-finance/ip079_en.pdf. Accessed 219, 2020.
   Google Scholar
• National Institute of Statistics Romania. Health status of the population in Romania (Institutul Naţional de Statistică România. Starea de sănătate a populaţiei din România); 2015:321 Available from: http://www.insse.ro/cms/sites/default/files/com_presa/com_pdf/sanatate2015r_0.pdf. Accessed 219, 2020.
   Google Scholar
• Ruiter R, Visser LE, Rodenburg EM, et al. Adverse drug reaction - Related hospitalizations in persons aged 55 years and over: a population-based study in the Netherlands. Drugs Aging. 2012;29(3):225–232. doi:10.2165/11599430-000000000-0000022372725
   PubMed Web of Science ®Google Scholar
• Sferrazza G, Nicotera G, Pierimarchi P. Suspected adverse drug reactions (ADRs) trends in older Italian patients: an analysis from the National Pharmacovigilance Network. Aging Clin Exp Res. 2019. doi:10.1007/s40520-019-01304-5
   Web of Science ®Google Scholar
• Bjerre LM, Ramsay T, Cahir C, et al. Assessing potentially inappropriate prescribing (PIP) and predicting patient outcomes in Ontario’s older population: a population-based cohort study applying subsets of the STOPP/START and Beers’ criteria in large health administrative databases. BMJ Open. 2015;5:e010146. doi:10.1136/bmjopen-2015-010146
   PubMed Web of Science ®Google Scholar
• Wauters M, Elseviers M, Vaes B, et al. Too many, too few, or too unsafe? Impact of inappropriate prescribing on mortality, and hospitalization in a cohort of community-dwelling oldest old. Br J Clin Pharmacol. 2016;82(5):1382–1392. doi:10.1111/bcp.1305527426227
   PubMed Web of Science ®Google Scholar
• Moriarty F, Bennett K, Cahir C, Kenny RA, Fahey T. Potentially inappropriate prescribing according to STOPP and START and adverse outcomes in community-dwelling older people: a prospective cohort study. Br J Clin Pharmacol. 2016;82(3):849–857. doi:10.1111/bcp.1299527136457
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global health and ageing; 2011 Available from: https://www.who.int/ageing/publications/global_health.pdf. Accessed 219, 2020.
   Google Scholar
• Miller GE, Sarpong EM, Davidoff AJ, Yang EY, Brandt NJ, Fick DM. Determinants of potentially inappropriate medication use among community-dwelling older adults. Health Serv Res. 2017;52(4):1534–1549. doi:10.1111/1475-6773.1256227686781
   PubMed Web of Science ®Google Scholar
• Primejdie DP, Bojita MT, Popa A. Potentially inappropriate medications in elderly ambulatory and institutionalized patients: an observational study. BMC Pharmacol Toxicol. 2016;17(1):38. doi:10.1186/s40360-016-0081-x27544266
   PubMed Web of Science ®Google Scholar
• Tommelein E, Mehuys E, Petrovic M, Somers A, Colin P, Boussery K. Potentially inappropriate prescribing in community-dwelling older people across Europe: a systematic literature review. Eur J Clin Pharmacol. 2015;71(12):1415–1427. doi:10.1007/s00228-015-1954-426407687
   PubMed Web of Science ®Google Scholar
• Ursulica ET. The Relationship between health care needs and accessibility to health care services in Botosani County- Romania. Procedia Environ Sci. 2016;32:300–310. doi:10.1016/j.proenv.2016.03.035
   Google Scholar
• Albulescu AC, Larion D. An analysis of the proximity based polarisation of the hospital network of Moldavia’s counties. Lucrarile Seminarului Geografic Dimitrie Cantemir. 2018;46(2):3–18. doi:10.15551/lsgdc.v46i2.01
   Google Scholar
• O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Aging. 2015;44:213–218. doi:10.1093/ageing/afu145
   PubMed Web of Science ®Google Scholar
• Ryan C, O’Mahony D, Kennedy J, Weedle P, Byrne S. Potentially inappropriate prescribing in an Irish elderly population in primary care. Br J Clin Pharmacol. 2009;68(6):936–947. doi:10.1111/j.1365-2125.2009.03531.x20002089
   PubMed Web of Science ®Google Scholar
• Curtain CM, Bindoff IK, Westbury JL, Peterson GM. A comparison of prescribing criteria when applied to older community-based patients. Drugs Aging. 2013;30(11):935–943. doi:10.1007/s40266-013-0116-624002743
   PubMed Web of Science ®Google Scholar
• CNAS. Available from: http://www.cnas.ro/media/pageFiles/Ghid%20prescriere%20Reteta.pdf. Accessed 219, 2020.
   Google Scholar
• CNAS. Available from: http://www.cnas.ro/casamm/post/type/local/regimul-juridic-al-plantelor-substantelor-si-preparatelor-stupefiante-si-psihotrope.html. Accessed 219, 2020.
   Google Scholar
• Eurostat. Mortality and life expectancy statistics; 2019 Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php/Mortality_and_life_expectancy_statistics. Accessed 219, 2020.
   Google Scholar
• CASDJ. Available form: www.casdj.ro/999cod.xls. Accessed 219, 2020.
   Google Scholar
• Eurostat. Cardiovascular diseases statistics; 2018 Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php/Cardiovascular_diseases_statistics#Deaths_from_cardiovascular_diseases. Accessed 219, 2020.
   Google Scholar
• Riordan DO, Aubert CE, Walsh KA. Prevalence of potentially inappropriate prescribing in a subpopulation of older European clinical trial participants: a cross-sectional study. BMJ Open. 2018;8(3):e019003. doi:10.1136/bmjopen-2017-019003
   Web of Science ®Google Scholar
• Kara Ö, Arık G, Kızılarslanoglu MC, et al. Potentially inappropriate prescribing according to the STOPP/START criteria for older adults. Aging Clin Exp Res. 2016;28(4):761–768. doi:10.1007/s40520-015-0475-426661647
   PubMed Web of Science ®Google Scholar
• Rodríguez-Blanco R, Álvarez-García M, Villalibre-Calderón C, et al. [Updated report on STOPP-START criteria in primary care]. Semergen. 2019;45(3):180–186. Spanish. doi:10.1016/j.semerg.2018.06.00430545673
   PubMedGoogle Scholar
• Vezmar Kovačević S, Simišić M, StojkovRudinski S, et al. Potentially inappropriate prescribing in older primary care patients. PLoS One. 2014;9(4):e95536. doi:10.1371/journal.pone.009553624763332
   PubMed Web of Science ®Google Scholar
• Moriarty F, Bennett K, Fahey T, Kenny RA, Cahir C. Longitudinal prevalence of potentially inappropriate medicines and potential prescribing omissions in a cohort of community-dwelling older people. Eur J Clin Pharmacol. 2015;71:473–482. doi:10.1007/s00228-015-1815-125666030
   PubMed Web of Science ®Google Scholar
• Cabassi A, Tedeschi S, Perlini S, et al. Non-steroidal anti-inflammatory drug effects on renal and cardiovascular function: from physiology to clinical practice. Eur J PrevCardiol. 2019;14:2047487319848105. doi:10.1177/2047487319848105
   Web of Science ®Google Scholar
• Masumoto S, Sato M, Maeno T, Ichinohe Y, Maeno T. Association between potentially inappropriate medications and anxiety in Japanese older patients. Geriatr Gerontol Int. 2017;17(12):2520–2526. doi:10.1111/ggi.1312828858424
   PubMed Web of Science ®Google Scholar
• Davies J, Rae TC, Montagu L. Long-term benzodiazepine and Z-drugs use in England: a survey of general practice [corrected]. Br J Gen Pract. 2017;67(662):e609–e613. doi:10.3399/bjgp17X69186528716996
   PubMed Web of Science ®Google Scholar
• Mo L, Ding D, Pu SY, et al. Patients aged 80 years or older are encountered more potentially inappropriate medication use. Chin Med J (Engl). 2016;129(1):22–27. doi:10.4103/0366-6999.17255826712428
   PubMed Web of Science ®Google Scholar
• Yazdanshenas H, Bazargan M, Smith J, Martins D, Motahari H, Orum G. Pain treatment of underserved older African Americans. J Am Geriatr Soc. 2016;64(10):2116–2121. doi:10.1111/jgs.1430227590566
   PubMed Web of Science ®Google Scholar
• Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J. A comprehensive review of non-steroidal antiinflammatory drug use in the elderly. Aging Dis. 2018;9(1):143–150. doi:10.14336/AD.2017.030629392089
   PubMed Web of Science ®Google Scholar
• Andor M, Dehelean L, Romosan AM, et al. A novel approach to cardiovascular disturbances in patients with schizophrenia spectrum disorders treated with long-acting injectable medication. Neuropsychiatr Dis Treat. 2019;15:349–355. doi:10.2147/NDT.S18689230774346
   PubMed Web of Science ®Google Scholar
• Dehelean L, Andor M, Romosan AM, Tomescu MC. Pharmacological and disorder associated cardiovascular changes in patients with psychosis. A comparison between olanzapine and risperidone. Farmacia. 2018;66(1):129–134.
   Web of Science ®Google Scholar
• World Health Organization Regional Office for Europe. Planning healthy and sustainable meetings; 2018 Available from: http://www.euro.who.int/en/health-topics/disease-prevention/nutrition/publications/2018/planning-healthy-and-sustainable-meetings-2018. Accessed 219, 2020.
   Google Scholar
• Dalton K, Byrne S. Role of the pharmacist in reducing healthcare costs: current insights. Integr Pharm Res Pract. 2017;6:37–46. doi:10.2147/IPRP.S10804729354549
   PubMed Web of Science ®Google Scholar
• Ryan C, O’Mahony D, O’Donovan DÓ, et al. A comparison of the application of STOPP/START to patients’ drug lists with and without clinical information. Int J Clin Pharm. 2013;35(2):230–235. doi:10.1007/s11096-012-9733-023225094
   PubMed Web of Science ®Google Scholar
• Getachew H, Bhagavathula AS, Abebe TB, Belachew SA. Inappropriate prescribing of antithrombotic therapy in Ethiopian elderly population using updated 2015 STOPP/START criteria: a cross-sectional study. Clin Interv Aging. 2016;11:819–827. doi:10.2147/CIA.S10739427382265
   PubMed Web of Science ®Google Scholar
• Delgado-Silveira E, Fernández-Villalba EM, García-Mina Freire M, et al. The impact of pharmacy intervention on the treatment of elderly multi-pathological patients. Farm Hosp. 2015;39(4):192–202. doi:10.7399/fh.2015.39.4.832926276737
   PubMedGoogle Scholar
• Cortejoso L, Dietz RA, Hofmann G, Gosch M, Sattler A. Impact of pharmacist interventions in older patients: a prospective study in a tertiary hospital in Germany. Clin Interv Aging. 2016;11:1343–1350. doi:10.2147/CIA.S10904827713625
   PubMed Web of Science ®Google Scholar
• Tommelein E, Petrovic M, Somers A, Mehuys E, van der Cammen T, Boussery K. Older patients’ prescriptions screening in the community pharmacy: development of the Ghent older people’s prescriptions community pharmacy screening (GheOP3S) tool. J Public Health (Oxf). 2016;38(2):e158–70. doi:10.1093/pubmed/fdv09026175537
   PubMed Web of Science ®Google Scholar
• Lin HW, Lin CH, Chang CK, et al. Economic outcome of pharmacist-physician medication therapy management for polypharmacy elderly: a prospective, randomized, controlled trial. J Formos Med Assoc. 2018;117(3):235–243. doi:10.1016/j.jfma.2017.04.01728549592
   PubMed Web of Science ®Google Scholar